Of the 40 recertification units (RUs) required for a CRNI® to recertify, at least 30 RUs must be obtained by attending any INS Meeting (live or online). Up to 10 RUs may be earned from the non INS Meeting category. The learning assets in this section have all been approved for RUs. Virtual Meetings and Conference Learning meet the INS Meeting criteria. Webinars meet the non INS Meeting criteria. All webinars are free to INS members.

CRNI® Recertification Approved

Search by Category
Search by Format
Sort By
Search by Keyword
  • Contains 3 Component(s), Includes Credits Includes a Live Web Event on 07/06/2022 at 4:30 PM (EDT)

    ​With the growing recognition of the infection risks of peripheral intravenous catheters (PIVC), many hospitals are implementing PIVC insertion and maintenance bundles. This presentation will review the evidence for PIVC bundles, discuss the essential components for such a bundle, explore implementation challenges, and emphasize compliance strategies. Infusion nurses who are considering implementing a PIVC insertion or maintenance bundle will benefit from this presentation.

    With the growing recognition of the infection risks of peripheral intravenous catheters (PIVC), many hospitals are implementing PIVC insertion and maintenance bundles. This presentation will review the evidence for PIVC bundles, discuss the essential components for such a bundle, explore implementation challenges, and emphasize compliance strategies. Infusion nurses who are considering implementing a PIVC insertion or maintenance bundle will benefit from this presentation.

    Learning Objectives: At the conclusion of this session, learners will be able to: 

    1.     Describe the common reasons for PIVC failure and the prevalence of PIVC bloodstream infection.

    2.     Review the history and rationale of the evidence-based bundle for bloodstream infection reduction.

    3.     Discuss the rationale for implementing a PIVC insertion and maintenance bundle.

    4.     Identify bundle components which have demonstrated reductions in PIVC–related bloodstream infection and other adverse events.

    5.     Discuss the challenges of bundle implementation and possible strategies to achieve compliance.

    Gillian Ray-Barruel, PhD, RN

    Senior Research Fellow

    University of Queensland School of Nursing, Midwifery, and Social Work

    Gillian Ray-Barruel, PhD, RN, is a senior research fellow with the University of Queensland School of Nursing, Midwifery, and Social Work and the Herston Infectious Diseases Institute (HeIDI), and an adjunct senior research fellow with Griffith University in Brisbane, Australia. She is also the education director for the Alliance for Vascular Access Teaching and Research (AVATAR). An experienced critical care nurse for 20 years, Dr. Ray-Barruel moved into vascular access research over 10 years ago and has published over 60 journal articles. Her research focuses on improving assessment and decision-making by clinicians to prevent device-related patient complications and to improve health care outcomes.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: July 6, 2025

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 3 Component(s), Includes Credits Recorded On: 06/15/2022

    ​Management of hypersensitivity infusion reactions (IRs) with H1-antihistamine premedication and/or treatment is recommended for several biologics and chemotherapies used in infusion centers. The sole second-generation intravenous H1-antihistamine recommended is cetirizine. In this session, the presenter will review key clinical data available with IV cetirizine as well as clinical profiles of first- and second-generation H1 antihistamines used to manage infusion reactions.

    image

    Management of hypersensitivity infusion reactions (IRs) with H1-antihistamine premedication and/or treatment is recommended for several biologics and chemotherapies used in infusion centers. The sole second-generation intravenous H1-antihistamine recommended is cetirizine. In this session, the presenter will review key clinical data available with IV cetirizine as well as clinical profiles of first- and second-generation H1 antihistamines used to manage infusion reactions.

    Learning Objectives: At the conclusion of this webinar, learners will be able to: 

    • Explain various infusion reactions and antihistamine use

    • Determine infusion reactions requiring a H1-antihistamine to treat a reaction or to prevent future reactions

    • Describe the use of IV H1-antihistamines

    • Determine which treatment options are the most appropriate for certain patients

    Ryan Haumschild, PharmD, MS, MBA

    Ryan Haumschild, PharmD, MS, MBA, is an experienced director of pharmacy, overseeing profit and loss responsibility, pharmacy operations, clinical services, formulary management, payer and health plan contracting, and medication use at the Winship Cancer Institute at Emory University, one of the nation’s largest academic integrated delivery networks and Georgia’s only National Cancer Institute (NCI)–designated comprehensive cancer center. Dr. Haumschild provides strategic direction on oncology and nononcology disease states, on infusion and specialty pharmacy services, and on the expansion of clinical services through treatment pathway development. He currently serves as an editorial board member at the American Journal of Managed Care® (AJMC®) and as a board member for the Institute of Safe Medication Practices (ISMP) and for the Center for Biosimilars, and was recently recognized as 40 under 40 by three separate organizations: University of Florida, Atlanta Business Chronicle, and Association for Value-Based Cancer Care.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: June 15, 2025

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 16 Product(s)

    INS 2022 Virtual Conference will provide a great alternative for those who are not able to attend the in-person event. Participants will have the ability to attend 15 select sessions virtually and on-demand. This option also enables CRNI®s to earn up to 30 recertification (RU) units. The virtual program will include the 5-hour veINS focus track on Monday, June 6 plus 10 additional one-hour sessions on Sunday, June 5.

    INS 2022 Virtual Conference will provide a great alternative for those who are not able to attend the in-person event. Participants will have the ability to attend 15 select sessions virtually and on-demand. This option also enables CRNI®s to earn up to 30 recertification (RU) units. The virtual program will include the 5-hour veINS focus track on Monday, June 6 plus 10 additional one-hour sessions on Sunday, June 5.  

  • Contains 3 Component(s), Includes Credits Recorded On: 05/18/2022

    ​There are many different forms of infusions that are administered to infants and children, and many are life-saving. However, they are also not without the potential for serious complications and morbidity. Infusion nurses are at the forefront of promoting safe, high-quality practices to prevent harm from this vital therapy. In this webinar, we will explore the strategies infusion nurses can employ to reduce harm to pediatric patients at their organization.

    There are many different forms of infusions that are administered to infants and children, and many are life-saving. However, they are also not without the potential for serious complications and morbidity. Infusion nurses are at the forefront of promoting safe, high-quality practices to prevent harm from this vital therapy. In this webinar, we will explore the strategies infusion nurses can employ to reduce harm to pediatric patients at their organization.

    Learning Objectives: At the conclusion of this webinar, learners will be able to: 

    ·      Describe the ethical duty of beneficence when caring for a patient receiving infusion therapy

    ·      Discuss two types of infusion injuries that have high-morbidity outcomes

    ·      List four strategies the infusion nurse can employ to reduce harm to the pediatric patient receiving infusion therapy at their organization

    Kristina Burger, DNP, APRN, CPNP-PC, CCRN, NPD-BC, LNC

    Dr. Kristina Burger has practiced pediatric nursing for 35 years and in a variety of settings from critical care to home care. She has provided extensive staff development on infusion therapy to all levels of nurses from new graduates to those providing home infusion services. She has also written numerous policies on infusion therapy and recently published a research paper testing the validity and reliability of a pediatric infiltration/extravasation staging tool with colleagues from Johns Hopkins All Children's Hospital.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: May 18, 2025

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 3 Component(s), Includes Credits Recorded On: 04/06/2022

    Infusion nurses play a vital role in inquiry work because they are uniquely able to identify opportunities for improvement in infusion therapy practice or potential patient safety problems. This webinar will provide an overview of inquiry and discuss the differences between the three types of inquiry including evidence-based practice (EBP), quality improvement (QI), and research. The basic evidence-based process will be examined, and participants will be introduced to three common EBP models. Resources to promote infusion nurse participation in inquiry and dissemination will also be explored.

    Infusion nurses play a vital role in inquiry work because they are uniquely able to identify opportunities for improvement in infusion therapy practice or potential patient safety problems. This webinar will provide an overview of inquiry and discuss the differences between the three types of inquiry including evidence-based practice (EBP), quality improvement (QI), and research. The basic evidence-based process will be examined, and participants will be introduced to three common EBP models. Resources to promote infusion nurse participation in inquiry and dissemination will also be explored.

    Learning objectives: At the completion of this webinar, learners will be able to:

    1.     Discuss the basic differences between evidence-based practice, quality improvement, and research

    2.     Describe the basic evidence-based practice process

    3.     State at least one common evidence-based practice model

    4.     Describe resources available to promote infusion nurse participation in inquiry and dissemination

    Genieveve Cline, PhD, DNP, APRN, NNP-BC, CNE, NPD-BC

    Assistant Professor, Director of the Education Concentration

    University of South Florida, College of Nursing

    Dr. Genieveve Cline is an assistant professor at the University of South Florida, College of Nursing, and the director of the education concentration. Dr. Cline graduated with her PhD as a nurse research scientist in 2018 from the University of South Florida, and received her Doctorate of Nursing Practice from the University of South Florida in 2009. She is certified as a neonatal nurse practitioner, an academic educator, and a nursing professional development specialist. She currently teaches research, evidence-based practice, organizational and systems leadership, and quality improvement in the graduate nursing program in addition to teaching the nurse educator curriculum. Prior to her current position, Dr. Cline was the director of nursing research and evidence-based practice at Johns Hopkins All Children's Hospital and taught multiple courses across the organization to prepare nurses for successful participation in inquiry. She regularly serves as a mentor for nurses completing research, evidence-based practice, and quality improvement projects. Her areas of research interest include interventions to improve clinical outcomes for infants with neonatal abstinence syndrome, and interventions to promote the utilization of science in health care.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: April 6, 2025

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 3 Component(s), Includes Credits Recorded On: 03/16/2022

    ​Many people do not understand what is happening with peripheral intravenous catheters (PIVCs), a seemingly innocuous device. Did you know that up to 69% of all PIVCs fail with an estimated excessive cost of $475,000 per 10,000 catheters used?—And the financial burden is only part of the story. Patient complications from PIVCs was number nine in the top 10 patient safety concerns in 2021, as identified by the ECRI Institute, one of the largest health care quality and safety entities in the world. To an observer, PIVCs often lie: we see no external signs and symptoms, and thus complications are often undetected. Yet when we look inside the vein, we see complications have begun, and we find the internal catheter positioning (the lie of the catheter) a contributing factor. Join us as we explore why the complications we see with PIVCs are late signs and symptoms of where the true problems lie.

    Many people do not understand what is happening with peripheral intravenous catheters (PIVCs), a seemingly innocuous device. Did you know that up to 69% of all PIVCs fail with an estimated excessive cost of $475,000 per 10,000 catheters used?—And the financial burden is only part of the story. Patient complications from PIVCs was number nine in the top 10 patient safety concerns in 2021, as identified by the ECRI Institute, one of the largest health care quality and safety entities in the world. To an observer, PIVCs often lie: we see no external signs and symptoms, and thus complications are often undetected. Yet when we look inside the vein, we see complications have begun, and we find the internal catheter positioning (the lie of the catheter) a contributing factor. Join us as we explore why the complications we see with PIVCs are late signs and symptoms of where the true problems lie.

    Learning Objectives:  At the conclusion of this presentation, learners will be able to:

    ·       Identify the prevalence of PIVC use and associated complications

    ·       Describe visually the impact of cannulation on vascular anatomy with use of case studies

    ·       Discuss the relationship between reported incidence of complications and actual practice

    ·       Summarize both the financial cost and patient outcomes involved with poor PIVC care

    ·       Discuss implementation in practice from the current INS Standards of Practice regarding PIVC placement and management

    S. Matthew Gibson, RN, CRNI®, VA-BC, CPUI

    CEO

    Vacllc

    Over the past decade, Matt has served national and local vascular access organizations, assumed leadership positions in multiple committees as a resident advisor, and been a published author in the area of vascular access. Currently Matt works as a vascular access consultant and speaker for various organizations. Matt is a certified registered nurse in infusion, is vascular access board certified, and is a certified PICC ultrasound user. He serves on the Association for Vascular Access (AVA) PIV Task Force and the AVA Public Policy Task Force, and is the CEO of Vascular Access Consulting LLC as well as the current president and founder of the Kentucky Indiana Vascular Access Network.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: March 16, 2025

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 6 Product(s)

    This Infusion Nurses Society virtual symposium addresses 5 challenging aspects involved in the delivery of infusion therapy: managing infusion reactions, preserving skin integrity, identifying and intervening with infiltrations and extravasations, and recognizing and managing implanted port complications and competency validation. Registrants will receive 5 Contact Hours and 10 Recertification Units and will have the ability to view anything they miss on-demand. This will be an informative and beneficial conference for all infusion professionals!

    This Infusion Nurses Society virtual symposium addresses 5 challenging aspects involved in the delivery of infusion therapy: managing infusion reactions, preserving skin integrity, identifying and intervening with infiltrations and extravasations, and recognizing and managing implanted port complications and competency validation. Registrants will receive 5 Contact Hours and 10 Recertification Units and will have the ability to view anything they miss on-demand. This will be an informative and beneficial conference for all infusion professionals!

  • Contains 3 Component(s), Includes Credits Recorded On: 02/16/2022

    ​The current opioid epidemic has caused a public health crisis in the spread of blood-borne pathogens and infections in people who inject drugs (PWID). An overview of common bacterial and viral complications will include skin and soft tissue infections, spinal epidural abscess, septic pulmonary embolism, infective endocarditis, retained needles, Clostridium botulinum and C. tetani wound infections, viral hepatitis, and human immunodeficiency virus. Promoting safe injection, safe sex practices, vaccinations, and substance use treatment are integral in preventing the infection and transmission of blood-borne pathogens. Participants will come away with a better understanding of the scope of the crisis and will be able to apply their expertise when caring for patients.

    The current opioid epidemic has caused a public health crisis in the spread of blood-borne pathogens and infections in people who inject drugs (PWID). An overview of common bacterial and viral complications will include skin and soft tissue infections, spinal epidural abscess, septic pulmonary embolism, infective endocarditis, retained needles, Clostridium botulinum and C. tetani wound infections, viral hepatitis, and human immunodeficiency virus. Promoting safe injection, safe sex practices, vaccinations, and substance use treatment are integral in preventing the infection and transmission of blood-borne pathogens. Participants will come away with a better understanding of the scope of the crisis and will be able to apply their expertise when caring for patients. 

    Learning Objectives: At the conclusion of this webinar, learners will be able to: 

    1.     Describe nursing assessment, interventions, and ongoing care of patients who inject drugs (PWID) that have an infectious complication

    2.     Identify the bacterial, fungal, and viral complications of intravenous drug use

    3.     Describe how Syringe Service Programs (SSPs) help to reduce infections in PWID

    Lynne Kokoczka, MSN, APRN-CNS, ACCNS-AG, CCRN

    Clinical Nurse Specialist

    Cleveland Clinic

    Lynne Kokoczka, MSN, APRN-CNS, ACCNS-AG, CCRN, is a clinical nurse specialist (CNS) for the Cleveland Clinic in Cleveland, Ohio. Lynne has been a registered nurse for 14 years and a CNS for 6 years. She has certifications in acute care, in adult gerontology, and in critical care. She is currently the CNS for a 64-bed medical intensive care unit which includes a subspecialty, the medical intensive liver unit. Her role includes offering expert consultation for clinical nurses.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: February 16, 2025

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 3 Component(s), Includes Credits Recorded On: 01/19/2022

    The National Institute for Occupational Safety and Health (NIOSH) provides an ongoing, continually revised list of drugs and biologic agents that meet the definition of hazardous drugs (HDs). Clinicians who prepare and administer hazardous drugs are potentially at risk by direct and indirect contact. Safe handling requirements, by the Occupational Safety and Health Administration (OSHA), NIOSH, USP 800, and INS 2021 Infusion Therapy Standards of Practice (SOPs), provide guidance to protect clinicians from hazardous drug exposure. Specifically, NIOSH recommends health care workers use a close system transfer device (CSTD) throughout the hazardous drug-handling chain, from drug compounding to administration. In this presentation, we will define hazardous drugs and clinician risk, discuss various safety requirements, evaluate various CSTDs, and learn to apply the INS 2021 SOPs into practice.

    image

    The National Institute for Occupational Safety and Health (NIOSH) provides an ongoing, continually revised list of drugs and biologic agents that meet the definition of hazardous drugs (HDs). Clinicians who prepare and administer hazardous drugs are potentially at risk by direct and indirect contact. Safe handling requirements, by the Occupational Safety and Health Administration (OSHA), NIOSH, USP 800, and INS 2021 Infusion Therapy Standards of Practice (SOPs), provide guidance to protect clinicians from hazardous drug exposure. Specifically, NIOSH recommends health care workers use a close system transfer device (CSTD) throughout the hazardous drug-handling chain, from drug compounding to administration. In this presentation, we will define hazardous drugs and clinician risk, discuss various safety requirements, evaluate various CSTDs, and learn to apply the INS 2021 SOPs into practice. 

    Learning Objectives: At the conclusion of this session, attendees will be able to:

    ·      Define hazardous drugs and clinician exposure risk

    ·      Verbalize various regulatory safety requirements, including OSHA, NIOSH, and USP 800

    ·      Evaluate various CSTDs for protective features

    ·      Apply into practice INS 2021 Infusion Therapy Standard of Practice #15: Hazardous Drugs and Waste

    Seth Eisenberg, RN, ASN, OCN®, BMTCN™

    Professional Practice Coordinator, Infusion Services

    Seattle Cancer Care Alliance

    Seth Eisenberg has been practicing in the field of oncology since 1983. His experience includes 35 years in bone marrow transplantation and 25 years in ambulatory oncology infusion. He has published numerous articles on chemotherapy and biotherapy, five book chapters, is as a contributing author to the Oncology Nursing Society (ONS) Safe Handling of Hazardous Drugs, and has presented nationally and internationally at nursing and pharmacy conferences. He received the 2017 March of Dimes research advancement award, the 2018 ONS Susan Baird Excellence in Clinical Writing Award, and the 2021 ONS Distinguished Award for Consistent Contribution to Nursing Literature.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification unit and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: January 19, 2025

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 3 Component(s), Includes Credits Recorded On: 12/15/2021

    For more than a century, vaccines have been a main factor in improving overall health and contributing to longer lifespans. However, over past few decades, people have become more reluctant to take vaccines, and this hesitancy has increased in regard to COVID-19 vaccines. How do we remain positive in a world of vaccine hesitancy? Through discussion and role-play, this session will review some factors that have led people to be vaccine hesitant and recommend how infusion nurses might discuss the COVID-19 vaccines with coworkers and patients.

    For more than a century, vaccines have been a main factor in improving overall health and contributing to longer lifespans. However, over past few decades, people have become more reluctant to take vaccines, and this hesitancy has increased in regard to COVID-19 vaccines. How do we remain positive in a world of vaccine hesitancy? Through discussion and role-play, this session will review some factors that have led people to be vaccine hesitant and recommend how infusion nurses might discuss the COVID-19 vaccines with coworkers and patients.

    Learning Objectives:  At the conclusion of this presentation, learners will be able to:

    1.     Verbalize factors that have contributed to hesitancy.

    2.     Identify steps in addressing vaccination status.

    3.     Promote positive vaccine messages.

    4.     Identify vaccine resources that the patient will accept as credible.

    5.     Ensure all staff are on board with promoting positive vaccine messages.

    Sheryl Buckner PhD, RN, ANEF

    University of Oklahoma (OU) College of Nursing

    Dr. Sheryl Buckner, a fellow in the Academy of Nursing Education for her work in Oklahoma Medical Reserve Corps and the Nursing Initiative Promoting Immunization Training, teaches at the University of Oklahoma (OU) College of Nursing, specializing in education, technology, and interprofessional collaboration. Since 2015, she has served as a National Advisory member, working with APTR, CDC, and AACN in developing Immunization Resources for Undergraduate Nursing. She has been a member of OU Interprofessional Educators and Practitioners Association (IEPA) since 2017, and in 2021, Dr. Buckner was part of a team awarded OU IEPA Team of the Year for their interprofessional work.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification unit and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: December 15, 2024

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.